nodes	percent_of_prediction	percent_of_DWPC	metapath
Vincristine—kidney cancer—thyroid cancer	0.447	1	CtDrD
Vincristine—RALBP1—Sorafenib—thyroid cancer	0.122	0.297	CbGbCtD
Vincristine—RALBP1—Doxorubicin—thyroid cancer	0.074	0.18	CbGbCtD
Vincristine—ABCC1—Vandetanib—thyroid cancer	0.0287	0.0699	CbGbCtD
Vincristine—ABCC10—Doxorubicin—thyroid cancer	0.0272	0.0662	CbGbCtD
Vincristine—ABCC1—Epirubicin—thyroid cancer	0.0197	0.0481	CbGbCtD
Vincristine—ABCG2—Vandetanib—thyroid cancer	0.0192	0.0467	CbGbCtD
Vincristine—ABCC3—Doxorubicin—thyroid cancer	0.0171	0.0416	CbGbCtD
Vincristine—ABCB11—Doxorubicin—thyroid cancer	0.0148	0.036	CbGbCtD
Vincristine—ABCC2—Sorafenib—thyroid cancer	0.0128	0.0312	CbGbCtD
Vincristine—ABCG2—Sorafenib—thyroid cancer	0.0116	0.0282	CbGbCtD
Vincristine—ABCC1—Doxorubicin—thyroid cancer	0.0105	0.0255	CbGbCtD
Vincristine—CYP3A7-CYP3A51P—Sorafenib—thyroid cancer	0.00854	0.0208	CbGbCtD
Vincristine—CYP3A7—Sorafenib—thyroid cancer	0.00854	0.0208	CbGbCtD
Vincristine—ABCC2—Doxorubicin—thyroid cancer	0.00776	0.0189	CbGbCtD
Vincristine—ABCG2—Doxorubicin—thyroid cancer	0.00702	0.0171	CbGbCtD
Vincristine—CYP3A5—Sorafenib—thyroid cancer	0.00641	0.0156	CbGbCtD
Vincristine—ABCB1—Sorafenib—thyroid cancer	0.00417	0.0102	CbGbCtD
Vincristine—CYP3A4—Vandetanib—thyroid cancer	0.00414	0.0101	CbGbCtD
Vincristine—ABCB1—Doxorubicin—thyroid cancer	0.00253	0.00616	CbGbCtD
Vincristine—CYP3A4—Sorafenib—thyroid cancer	0.0025	0.00609	CbGbCtD
Vincristine—CYP3A4—Doxorubicin—thyroid cancer	0.00152	0.00369	CbGbCtD
Vincristine—TUBB8—head—thyroid cancer	0.00109	0.0377	CbGeAlD
Vincristine—TUBA4A—saliva-secreting gland—thyroid cancer	0.00104	0.0361	CbGeAlD
Vincristine—RALBP1—saliva-secreting gland—thyroid cancer	0.000981	0.034	CbGeAlD
Vincristine—TUBB2B—saliva-secreting gland—thyroid cancer	0.000806	0.0279	CbGeAlD
Vincristine—TUBA4A—trachea—thyroid cancer	0.000803	0.0278	CbGeAlD
Vincristine—TUBB—saliva-secreting gland—thyroid cancer	0.000763	0.0264	CbGeAlD
Vincristine—TUBB2A—saliva-secreting gland—thyroid cancer	0.000759	0.0263	CbGeAlD
Vincristine—RALBP1—trachea—thyroid cancer	0.000757	0.0262	CbGeAlD
Vincristine—TUBA4A—Afatinib—Vandetanib—thyroid cancer	0.000755	0.249	CbGdCrCtD
Vincristine—TUBB6—saliva-secreting gland—thyroid cancer	0.000748	0.0259	CbGeAlD
Vincristine—TUBB3—head—thyroid cancer	0.000742	0.0257	CbGeAlD
Vincristine—TUBB1—head—thyroid cancer	0.000725	0.0252	CbGeAlD
Vincristine—TUBB3—Afatinib—Vandetanib—thyroid cancer	0.000673	0.222	CbGdCrCtD
Vincristine—TUBA4A—Gefitinib—Vandetanib—thyroid cancer	0.00066	0.218	CbGdCrCtD
Vincristine—ABCC10—saliva-secreting gland—thyroid cancer	0.000655	0.0227	CbGeAlD
Vincristine—TUBB4B—saliva-secreting gland—thyroid cancer	0.00065	0.0226	CbGeAlD
Vincristine—TUBA4A—thyroid gland—thyroid cancer	0.000635	0.022	CbGeAlD
Vincristine—TUBB2B—trachea—thyroid cancer	0.000622	0.0216	CbGeAlD
Vincristine—RALBP1—thyroid gland—thyroid cancer	0.000598	0.0207	CbGeAlD
Vincristine—TUBB—trachea—thyroid cancer	0.000588	0.0204	CbGeAlD
Vincristine—TUBB2A—trachea—thyroid cancer	0.000585	0.0203	CbGeAlD
Vincristine—TUBB6—trachea—thyroid cancer	0.000577	0.02	CbGeAlD
Vincristine—TUBA4A—head—thyroid cancer	0.000563	0.0195	CbGeAlD
Vincristine—SLC22A3—saliva-secreting gland—thyroid cancer	0.00056	0.0194	CbGeAlD
Vincristine—RALBP1—head—thyroid cancer	0.000531	0.0184	CbGeAlD
Vincristine—TUBB4A—thyroid gland—thyroid cancer	0.000509	0.0176	CbGeAlD
Vincristine—ABCC10—trachea—thyroid cancer	0.000505	0.0175	CbGeAlD
Vincristine—TUBB4B—trachea—thyroid cancer	0.000502	0.0174	CbGeAlD
Vincristine—Neuropathy—Sorafenib—thyroid cancer	0.000498	0.0074	CcSEcCtD
Vincristine—TUBB2B—thyroid gland—thyroid cancer	0.000492	0.0171	CbGeAlD
Vincristine—Mouth ulceration—Sorafenib—thyroid cancer	0.00048	0.00713	CcSEcCtD
Vincristine—Neurotoxicity—Doxorubicin—thyroid cancer	0.000468	0.00695	CcSEcCtD
Vincristine—TUBB—thyroid gland—thyroid cancer	0.000465	0.0161	CbGeAlD
Vincristine—TUBB2A—thyroid gland—thyroid cancer	0.000463	0.0161	CbGeAlD
Vincristine—Neutropenia—Vandetanib—thyroid cancer	0.000462	0.00686	CcSEcCtD
Vincristine—Dysuria—Vandetanib—thyroid cancer	0.000462	0.00686	CcSEcCtD
Vincristine—TUBB6—thyroid gland—thyroid cancer	0.000457	0.0158	CbGeAlD
Vincristine—TUBB4A—head—thyroid cancer	0.000451	0.0157	CbGeAlD
Vincristine—Photosensitivity reaction—Vandetanib—thyroid cancer	0.000451	0.00669	CcSEcCtD
Vincristine—Weight decreased—Vandetanib—thyroid cancer	0.000447	0.00663	CcSEcCtD
Vincristine—Pneumonia—Vandetanib—thyroid cancer	0.000443	0.00658	CcSEcCtD
Vincristine—Depression—Vandetanib—thyroid cancer	0.000439	0.00652	CcSEcCtD
Vincristine—TUBB2B—head—thyroid cancer	0.000436	0.0151	CbGeAlD
Vincristine—Hyporeflexia—Epirubicin—thyroid cancer	0.000432	0.00641	CcSEcCtD
Vincristine—Stomatitis—Vandetanib—thyroid cancer	0.000429	0.00637	CcSEcCtD
Vincristine—Hepatic failure—Sorafenib—thyroid cancer	0.000429	0.00637	CcSEcCtD
Vincristine—Myelosuppression—Epirubicin—thyroid cancer	0.000418	0.00621	CcSEcCtD
Vincristine—TUBB4B—Afatinib—Vandetanib—thyroid cancer	0.000416	0.137	CbGdCrCtD
Vincristine—TUBB2A—head—thyroid cancer	0.000411	0.0142	CbGeAlD
Vincristine—TUBB6—head—thyroid cancer	0.000405	0.014	CbGeAlD
Vincristine—ABCC3—thyroid gland—thyroid cancer	0.000402	0.0139	CbGeAlD
Vincristine—ABCC10—thyroid gland—thyroid cancer	0.0004	0.0139	CbGeAlD
Vincristine—Hyporeflexia—Doxorubicin—thyroid cancer	0.000399	0.00593	CcSEcCtD
Vincristine—TUBB4B—thyroid gland—thyroid cancer	0.000397	0.0138	CbGeAlD
Vincristine—TUBA4A—lymph node—thyroid cancer	0.000394	0.0137	CbGeAlD
Vincristine—Urinary tract disorder—Vandetanib—thyroid cancer	0.00039	0.0058	CcSEcCtD
Vincristine—Urethral disorder—Vandetanib—thyroid cancer	0.000387	0.00575	CcSEcCtD
Vincristine—Myelosuppression—Doxorubicin—thyroid cancer	0.000387	0.00575	CcSEcCtD
Vincristine—Hyponatraemia—Sorafenib—thyroid cancer	0.000387	0.00575	CcSEcCtD
Vincristine—Pain in extremity—Sorafenib—thyroid cancer	0.000385	0.00572	CcSEcCtD
Vincristine—ABCG2—saliva-secreting gland—thyroid cancer	0.000384	0.0133	CbGeAlD
Vincristine—RALBP1—lymph node—thyroid cancer	0.000372	0.0129	CbGeAlD
Vincristine—Cardiac disorder—Vandetanib—thyroid cancer	0.000367	0.00545	CcSEcCtD
Vincristine—Angiopathy—Vandetanib—thyroid cancer	0.000359	0.00532	CcSEcCtD
Vincristine—Dehydration—Sorafenib—thyroid cancer	0.000358	0.00532	CcSEcCtD
Vincristine—ABCC1—trachea—thyroid cancer	0.000357	0.0124	CbGeAlD
Vincristine—ABCC3—head—thyroid cancer	0.000356	0.0124	CbGeAlD
Vincristine—Mediastinal disorder—Vandetanib—thyroid cancer	0.000356	0.00529	CcSEcCtD
Vincristine—Blindness—Epirubicin—thyroid cancer	0.000354	0.00526	CcSEcCtD
Vincristine—TUBB4B—head—thyroid cancer	0.000352	0.0122	CbGeAlD
Vincristine—Alopecia—Vandetanib—thyroid cancer	0.000349	0.00519	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Sorafenib—thyroid cancer	0.000347	0.00515	CcSEcCtD
Vincristine—Mental disorder—Vandetanib—thyroid cancer	0.000346	0.00514	CcSEcCtD
Vincristine—SLC22A3—thyroid gland—thyroid cancer	0.000342	0.0119	CbGeAlD
Vincristine—Blindness—Doxorubicin—thyroid cancer	0.000328	0.00487	CcSEcCtD
Vincristine—Febrile neutropenia—Epirubicin—thyroid cancer	0.000326	0.00484	CcSEcCtD
Vincristine—TUBB6—Erlotinib—Vandetanib—thyroid cancer	0.000317	0.105	CbGdCrCtD
Vincristine—TUBB4A—lymph node—thyroid cancer	0.000316	0.011	CbGeAlD
Vincristine—Neutropenia—Sorafenib—thyroid cancer	0.000311	0.00462	CcSEcCtD
Vincristine—Erectile dysfunction—Sorafenib—thyroid cancer	0.000307	0.00456	CcSEcCtD
Vincristine—TUBB2B—lymph node—thyroid cancer	0.000306	0.0106	CbGeAlD
Vincristine—SLC22A3—head—thyroid cancer	0.000303	0.0105	CbGeAlD
Vincristine—Febrile neutropenia—Doxorubicin—thyroid cancer	0.000302	0.00448	CcSEcCtD
Vincristine—Weight decreased—Sorafenib—thyroid cancer	0.000301	0.00447	CcSEcCtD
Vincristine—Pneumonia—Sorafenib—thyroid cancer	0.000299	0.00444	CcSEcCtD
Vincristine—Convulsion—Vandetanib—thyroid cancer	0.000298	0.00443	CcSEcCtD
Vincristine—Hypertension—Vandetanib—thyroid cancer	0.000297	0.00441	CcSEcCtD
Vincristine—Acute coronary syndrome—Sorafenib—thyroid cancer	0.000293	0.00435	CcSEcCtD
Vincristine—Neuropathy peripheral—Sorafenib—thyroid cancer	0.000291	0.00432	CcSEcCtD
Vincristine—Myocardial infarction—Sorafenib—thyroid cancer	0.000291	0.00432	CcSEcCtD
Vincristine—Bone marrow depression—Epirubicin—thyroid cancer	0.000291	0.00432	CcSEcCtD
Vincristine—Stomatitis—Sorafenib—thyroid cancer	0.000289	0.0043	CcSEcCtD
Vincristine—TUBB—lymph node—thyroid cancer	0.000289	0.01	CbGeAlD
Vincristine—TUBB2A—lymph node—thyroid cancer	0.000288	0.00997	CbGeAlD
Vincristine—TUBB6—lymph node—thyroid cancer	0.000284	0.00983	CbGeAlD
Vincristine—ABCC1—thyroid gland—thyroid cancer	0.000283	0.0098	CbGeAlD
Vincristine—Paralysis—Epirubicin—thyroid cancer	0.000282	0.00419	CcSEcCtD
Vincristine—Oedema—Vandetanib—thyroid cancer	0.000281	0.00417	CcSEcCtD
Vincristine—Infection—Vandetanib—thyroid cancer	0.000279	0.00414	CcSEcCtD
Vincristine—Ileus—Epirubicin—thyroid cancer	0.000277	0.00412	CcSEcCtD
Vincristine—Nervous system disorder—Vandetanib—thyroid cancer	0.000275	0.00409	CcSEcCtD
Vincristine—Thrombocytopenia—Vandetanib—thyroid cancer	0.000275	0.00408	CcSEcCtD
Vincristine—Nystagmus—Epirubicin—thyroid cancer	0.000275	0.00408	CcSEcCtD
Vincristine—Bone marrow depression—Doxorubicin—thyroid cancer	0.000269	0.00399	CcSEcCtD
Vincristine—Urinary tract disorder—Sorafenib—thyroid cancer	0.000263	0.00391	CcSEcCtD
Vincristine—Neuritis—Epirubicin—thyroid cancer	0.000263	0.0039	CcSEcCtD
Vincristine—Connective tissue disorder—Sorafenib—thyroid cancer	0.000262	0.00389	CcSEcCtD
Vincristine—Urethral disorder—Sorafenib—thyroid cancer	0.000261	0.00388	CcSEcCtD
Vincristine—Paralysis—Doxorubicin—thyroid cancer	0.000261	0.00388	CcSEcCtD
Vincristine—Ileus—Doxorubicin—thyroid cancer	0.000256	0.00381	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.000256	0.0038	CcSEcCtD
Vincristine—Nystagmus—Doxorubicin—thyroid cancer	0.000254	0.00377	CcSEcCtD
Vincristine—Insomnia—Vandetanib—thyroid cancer	0.000254	0.00377	CcSEcCtD
Vincristine—Paraesthesia—Vandetanib—thyroid cancer	0.000252	0.00374	CcSEcCtD
Vincristine—ABCC3—lymph node—thyroid cancer	0.00025	0.00865	CbGeAlD
Vincristine—ABCC10—lymph node—thyroid cancer	0.000248	0.00861	CbGeAlD
Vincristine—Cardiac disorder—Sorafenib—thyroid cancer	0.000247	0.00367	CcSEcCtD
Vincristine—TUBB4B—lymph node—thyroid cancer	0.000247	0.00855	CbGeAlD
Vincristine—Decreased appetite—Vandetanib—thyroid cancer	0.000244	0.00362	CcSEcCtD
Vincristine—Neuritis—Doxorubicin—thyroid cancer	0.000243	0.00361	CcSEcCtD
Vincristine—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.000242	0.0036	CcSEcCtD
Vincristine—Fatigue—Vandetanib—thyroid cancer	0.000242	0.00359	CcSEcCtD
Vincristine—Angiopathy—Sorafenib—thyroid cancer	0.000242	0.00359	CcSEcCtD
Vincristine—Mediastinal disorder—Sorafenib—thyroid cancer	0.00024	0.00357	CcSEcCtD
Vincristine—Pain—Vandetanib—thyroid cancer	0.00024	0.00357	CcSEcCtD
Vincristine—Constipation—Vandetanib—thyroid cancer	0.00024	0.00357	CcSEcCtD
Vincristine—Alopecia—Sorafenib—thyroid cancer	0.000236	0.0035	CcSEcCtD
Vincristine—ABCG2—thyroid gland—thyroid cancer	0.000234	0.00812	CbGeAlD
Vincristine—Mental disorder—Sorafenib—thyroid cancer	0.000234	0.00347	CcSEcCtD
Vincristine—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00023	0.00341	CcSEcCtD
Vincristine—Extravasation—Epirubicin—thyroid cancer	0.000225	0.00334	CcSEcCtD
Vincristine—Abdominal pain—Vandetanib—thyroid cancer	0.000222	0.0033	CcSEcCtD
Vincristine—Body temperature increased—Vandetanib—thyroid cancer	0.000222	0.0033	CcSEcCtD
Vincristine—Anaemia—Sorafenib—thyroid cancer	0.000214	0.00319	CcSEcCtD
Vincristine—SLC22A3—lymph node—thyroid cancer	0.000212	0.00737	CbGeAlD
Vincristine—Hyperuricaemia—Epirubicin—thyroid cancer	0.000211	0.00314	CcSEcCtD
Vincristine—Extravasation—Doxorubicin—thyroid cancer	0.000208	0.00309	CcSEcCtD
Vincristine—Leukopenia—Sorafenib—thyroid cancer	0.000208	0.00308	CcSEcCtD
Vincristine—TUBB6—Afatinib—Vandetanib—thyroid cancer	0.000207	0.0684	CbGdCrCtD
Vincristine—Bone pain—Epirubicin—thyroid cancer	0.000205	0.00304	CcSEcCtD
Vincristine—Asthenia—Vandetanib—thyroid cancer	0.000201	0.00299	CcSEcCtD
Vincristine—Gait disturbance—Epirubicin—thyroid cancer	0.000201	0.00299	CcSEcCtD
Vincristine—Hypertension—Sorafenib—thyroid cancer	0.0002	0.00298	CcSEcCtD
Vincristine—Blood uric acid increased—Epirubicin—thyroid cancer	0.0002	0.00297	CcSEcCtD
Vincristine—ABCC2—lymph node—thyroid cancer	0.000199	0.00691	CbGeAlD
Vincristine—Musculoskeletal pain—Epirubicin—thyroid cancer	0.000199	0.00295	CcSEcCtD
Vincristine—Myalgia—Sorafenib—thyroid cancer	0.000198	0.00293	CcSEcCtD
Vincristine—Hyperuricaemia—Doxorubicin—thyroid cancer	0.000196	0.00291	CcSEcCtD
Vincristine—Diarrhoea—Vandetanib—thyroid cancer	0.000192	0.00285	CcSEcCtD
Vincristine—Bone pain—Doxorubicin—thyroid cancer	0.000189	0.00281	CcSEcCtD
Vincristine—Anaphylactic shock—Sorafenib—thyroid cancer	0.000189	0.00281	CcSEcCtD
Vincristine—Infection—Sorafenib—thyroid cancer	0.000188	0.00279	CcSEcCtD
Vincristine—Gait disturbance—Doxorubicin—thyroid cancer	0.000186	0.00276	CcSEcCtD
Vincristine—Nervous system disorder—Sorafenib—thyroid cancer	0.000186	0.00276	CcSEcCtD
Vincristine—Dizziness—Vandetanib—thyroid cancer	0.000186	0.00276	CcSEcCtD
Vincristine—Thrombocytopenia—Sorafenib—thyroid cancer	0.000185	0.00275	CcSEcCtD
Vincristine—Blood uric acid increased—Doxorubicin—thyroid cancer	0.000185	0.00275	CcSEcCtD
Vincristine—Neuropathy—Epirubicin—thyroid cancer	0.000184	0.00274	CcSEcCtD
Vincristine—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.000184	0.00273	CcSEcCtD
Vincristine—Anorexia—Sorafenib—thyroid cancer	0.000181	0.00268	CcSEcCtD
Vincristine—Coma—Epirubicin—thyroid cancer	0.000179	0.00266	CcSEcCtD
Vincristine—Vomiting—Vandetanib—thyroid cancer	0.000179	0.00265	CcSEcCtD
Vincristine—Mouth ulceration—Epirubicin—thyroid cancer	0.000177	0.00263	CcSEcCtD
Vincristine—Rash—Vandetanib—thyroid cancer	0.000177	0.00263	CcSEcCtD
Vincristine—Dermatitis—Vandetanib—thyroid cancer	0.000177	0.00263	CcSEcCtD
Vincristine—Headache—Vandetanib—thyroid cancer	0.000176	0.00261	CcSEcCtD
Vincristine—ABCC1—lymph node—thyroid cancer	0.000176	0.00609	CbGeAlD
Vincristine—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000173	0.00256	CcSEcCtD
Vincristine—Neuropathy—Doxorubicin—thyroid cancer	0.00017	0.00253	CcSEcCtD
Vincristine—Nausea—Vandetanib—thyroid cancer	0.000167	0.00248	CcSEcCtD
Vincristine—Coma—Doxorubicin—thyroid cancer	0.000166	0.00246	CcSEcCtD
Vincristine—Decreased appetite—Sorafenib—thyroid cancer	0.000165	0.00244	CcSEcCtD
Vincristine—Mouth ulceration—Doxorubicin—thyroid cancer	0.000164	0.00244	CcSEcCtD
Vincristine—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000164	0.00243	CcSEcCtD
Vincristine—Fatigue—Sorafenib—thyroid cancer	0.000163	0.00242	CcSEcCtD
Vincristine—Constipation—Sorafenib—thyroid cancer	0.000162	0.00241	CcSEcCtD
Vincristine—Pain—Sorafenib—thyroid cancer	0.000162	0.00241	CcSEcCtD
Vincristine—Hepatic failure—Epirubicin—thyroid cancer	0.000158	0.00235	CcSEcCtD
Vincristine—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000155	0.0023	CcSEcCtD
Vincristine—Body temperature increased—Sorafenib—thyroid cancer	0.00015	0.00222	CcSEcCtD
Vincristine—Abdominal pain—Sorafenib—thyroid cancer	0.00015	0.00222	CcSEcCtD
Vincristine—Hepatic failure—Doxorubicin—thyroid cancer	0.000147	0.00218	CcSEcCtD
Vincristine—ABCB1—trachea—thyroid cancer	0.000146	0.00506	CbGeAlD
Vincristine—ABCG2—lymph node—thyroid cancer	0.000145	0.00504	CbGeAlD
Vincristine—Hyponatraemia—Epirubicin—thyroid cancer	0.000143	0.00212	CcSEcCtD
Vincristine—Pain in extremity—Epirubicin—thyroid cancer	0.000142	0.00211	CcSEcCtD
Vincristine—Hypersensitivity—Sorafenib—thyroid cancer	0.00014	0.00207	CcSEcCtD
Vincristine—Asthenia—Sorafenib—thyroid cancer	0.000136	0.00202	CcSEcCtD
Vincristine—Cardiac arrest—Epirubicin—thyroid cancer	0.000135	0.00201	CcSEcCtD
Vincristine—Ataxia—Epirubicin—thyroid cancer	0.000134	0.00199	CcSEcCtD
Vincristine—Dehydration—Epirubicin—thyroid cancer	0.000132	0.00197	CcSEcCtD
Vincristine—Hyponatraemia—Doxorubicin—thyroid cancer	0.000132	0.00196	CcSEcCtD
Vincristine—Pain in extremity—Doxorubicin—thyroid cancer	0.000132	0.00196	CcSEcCtD
Vincristine—Diarrhoea—Sorafenib—thyroid cancer	0.00013	0.00192	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000128	0.0019	CcSEcCtD
Vincristine—Muscular weakness—Epirubicin—thyroid cancer	0.000126	0.00187	CcSEcCtD
Vincristine—Cardiac arrest—Doxorubicin—thyroid cancer	0.000125	0.00186	CcSEcCtD
Vincristine—Dizziness—Sorafenib—thyroid cancer	0.000125	0.00186	CcSEcCtD
Vincristine—Ataxia—Doxorubicin—thyroid cancer	0.000124	0.00184	CcSEcCtD
Vincristine—Dehydration—Doxorubicin—thyroid cancer	0.000123	0.00182	CcSEcCtD
Vincristine—Vomiting—Sorafenib—thyroid cancer	0.00012	0.00179	CcSEcCtD
Vincristine—Rash—Sorafenib—thyroid cancer	0.000119	0.00177	CcSEcCtD
Vincristine—Dermatitis—Sorafenib—thyroid cancer	0.000119	0.00177	CcSEcCtD
Vincristine—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000119	0.00176	CcSEcCtD
Vincristine—Headache—Sorafenib—thyroid cancer	0.000119	0.00176	CcSEcCtD
Vincristine—Pancytopenia—Epirubicin—thyroid cancer	0.000117	0.00174	CcSEcCtD
Vincristine—Muscular weakness—Doxorubicin—thyroid cancer	0.000116	0.00173	CcSEcCtD
Vincristine—ABCB1—thyroid gland—thyroid cancer	0.000115	0.004	CbGeAlD
Vincristine—Neutropenia—Epirubicin—thyroid cancer	0.000115	0.00171	CcSEcCtD
Vincristine—Dysuria—Epirubicin—thyroid cancer	0.000115	0.00171	CcSEcCtD
Vincristine—Nausea—Sorafenib—thyroid cancer	0.000112	0.00167	CcSEcCtD
Vincristine—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000112	0.00167	CcSEcCtD
Vincristine—Weight decreased—Epirubicin—thyroid cancer	0.000111	0.00165	CcSEcCtD
Vincristine—Pneumonia—Epirubicin—thyroid cancer	0.00011	0.00164	CcSEcCtD
Vincristine—Pancytopenia—Doxorubicin—thyroid cancer	0.000108	0.00161	CcSEcCtD
Vincristine—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000108	0.0016	CcSEcCtD
Vincristine—Stomatitis—Epirubicin—thyroid cancer	0.000107	0.00159	CcSEcCtD
Vincristine—Dysuria—Doxorubicin—thyroid cancer	0.000106	0.00158	CcSEcCtD
Vincristine—Neutropenia—Doxorubicin—thyroid cancer	0.000106	0.00158	CcSEcCtD
Vincristine—Sweating—Epirubicin—thyroid cancer	0.000105	0.00156	CcSEcCtD
Vincristine—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000104	0.00154	CcSEcCtD
Vincristine—Weight decreased—Doxorubicin—thyroid cancer	0.000103	0.00153	CcSEcCtD
Vincristine—ABCB1—head—thyroid cancer	0.000102	0.00355	CbGeAlD
Vincristine—Pneumonia—Doxorubicin—thyroid cancer	0.000102	0.00152	CcSEcCtD
Vincristine—Neuropathy peripheral—Doxorubicin—thyroid cancer	9.95e-05	0.00148	CcSEcCtD
Vincristine—Stomatitis—Doxorubicin—thyroid cancer	9.9e-05	0.00147	CcSEcCtD
Vincristine—Hypoaesthesia—Epirubicin—thyroid cancer	9.8e-05	0.00146	CcSEcCtD
Vincristine—Sweating—Doxorubicin—thyroid cancer	9.73e-05	0.00145	CcSEcCtD
Vincristine—Urinary tract disorder—Epirubicin—thyroid cancer	9.73e-05	0.00144	CcSEcCtD
Vincristine—Connective tissue disorder—Epirubicin—thyroid cancer	9.68e-05	0.00144	CcSEcCtD
Vincristine—Urethral disorder—Epirubicin—thyroid cancer	9.66e-05	0.00143	CcSEcCtD
Vincristine—Cardiac disorder—Epirubicin—thyroid cancer	9.14e-05	0.00136	CcSEcCtD
Vincristine—Hypoaesthesia—Doxorubicin—thyroid cancer	9.07e-05	0.00135	CcSEcCtD
Vincristine—Urinary tract disorder—Doxorubicin—thyroid cancer	9e-05	0.00134	CcSEcCtD
Vincristine—Connective tissue disorder—Doxorubicin—thyroid cancer	8.96e-05	0.00133	CcSEcCtD
Vincristine—Angiopathy—Epirubicin—thyroid cancer	8.94e-05	0.00133	CcSEcCtD
Vincristine—Urethral disorder—Doxorubicin—thyroid cancer	8.94e-05	0.00133	CcSEcCtD
Vincristine—Mediastinal disorder—Epirubicin—thyroid cancer	8.88e-05	0.00132	CcSEcCtD
Vincristine—Alopecia—Epirubicin—thyroid cancer	8.71e-05	0.00129	CcSEcCtD
Vincristine—Mental disorder—Epirubicin—thyroid cancer	8.63e-05	0.00128	CcSEcCtD
Vincristine—Cardiac disorder—Doxorubicin—thyroid cancer	8.46e-05	0.00126	CcSEcCtD
Vincristine—Back pain—Epirubicin—thyroid cancer	8.3e-05	0.00123	CcSEcCtD
Vincristine—Angiopathy—Doxorubicin—thyroid cancer	8.27e-05	0.00123	CcSEcCtD
Vincristine—Mediastinal disorder—Doxorubicin—thyroid cancer	8.22e-05	0.00122	CcSEcCtD
Vincristine—Alopecia—Doxorubicin—thyroid cancer	8.05e-05	0.0012	CcSEcCtD
Vincristine—Mental disorder—Doxorubicin—thyroid cancer	7.99e-05	0.00119	CcSEcCtD
Vincristine—Anaemia—Epirubicin—thyroid cancer	7.93e-05	0.00118	CcSEcCtD
Vincristine—Agitation—Epirubicin—thyroid cancer	7.88e-05	0.00117	CcSEcCtD
Vincristine—Vertigo—Epirubicin—thyroid cancer	7.7e-05	0.00114	CcSEcCtD
Vincristine—Leukopenia—Epirubicin—thyroid cancer	7.68e-05	0.00114	CcSEcCtD
Vincristine—Back pain—Doxorubicin—thyroid cancer	7.68e-05	0.00114	CcSEcCtD
Vincristine—Convulsion—Epirubicin—thyroid cancer	7.43e-05	0.0011	CcSEcCtD
Vincristine—Hypertension—Epirubicin—thyroid cancer	7.4e-05	0.0011	CcSEcCtD
Vincristine—Anaemia—Doxorubicin—thyroid cancer	7.33e-05	0.00109	CcSEcCtD
Vincristine—Myalgia—Epirubicin—thyroid cancer	7.3e-05	0.00108	CcSEcCtD
Vincristine—Agitation—Doxorubicin—thyroid cancer	7.29e-05	0.00108	CcSEcCtD
Vincristine—ABCB1—lymph node—thyroid cancer	7.17e-05	0.00249	CbGeAlD
Vincristine—Vertigo—Doxorubicin—thyroid cancer	7.13e-05	0.00106	CcSEcCtD
Vincristine—Leukopenia—Doxorubicin—thyroid cancer	7.1e-05	0.00105	CcSEcCtD
Vincristine—Oedema—Epirubicin—thyroid cancer	7e-05	0.00104	CcSEcCtD
Vincristine—Anaphylactic shock—Epirubicin—thyroid cancer	7e-05	0.00104	CcSEcCtD
Vincristine—Infection—Epirubicin—thyroid cancer	6.95e-05	0.00103	CcSEcCtD
Vincristine—Convulsion—Doxorubicin—thyroid cancer	6.88e-05	0.00102	CcSEcCtD
Vincristine—Nervous system disorder—Epirubicin—thyroid cancer	6.86e-05	0.00102	CcSEcCtD
Vincristine—Thrombocytopenia—Epirubicin—thyroid cancer	6.85e-05	0.00102	CcSEcCtD
Vincristine—Hypertension—Doxorubicin—thyroid cancer	6.85e-05	0.00102	CcSEcCtD
Vincristine—Hyperhidrosis—Epirubicin—thyroid cancer	6.77e-05	0.001	CcSEcCtD
Vincristine—Myalgia—Doxorubicin—thyroid cancer	6.76e-05	0.001	CcSEcCtD
Vincristine—Anorexia—Epirubicin—thyroid cancer	6.67e-05	0.000991	CcSEcCtD
Vincristine—Hypotension—Epirubicin—thyroid cancer	6.54e-05	0.000971	CcSEcCtD
Vincristine—Anaphylactic shock—Doxorubicin—thyroid cancer	6.48e-05	0.000962	CcSEcCtD
Vincristine—Oedema—Doxorubicin—thyroid cancer	6.48e-05	0.000962	CcSEcCtD
Vincristine—Infection—Doxorubicin—thyroid cancer	6.43e-05	0.000955	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Epirubicin—thyroid cancer	6.38e-05	0.000947	CcSEcCtD
Vincristine—Nervous system disorder—Doxorubicin—thyroid cancer	6.35e-05	0.000943	CcSEcCtD
Vincristine—Thrombocytopenia—Doxorubicin—thyroid cancer	6.34e-05	0.000942	CcSEcCtD
Vincristine—Insomnia—Epirubicin—thyroid cancer	6.33e-05	0.00094	CcSEcCtD
Vincristine—Paraesthesia—Epirubicin—thyroid cancer	6.28e-05	0.000933	CcSEcCtD
Vincristine—Hyperhidrosis—Doxorubicin—thyroid cancer	6.26e-05	0.00093	CcSEcCtD
Vincristine—Anorexia—Doxorubicin—thyroid cancer	6.17e-05	0.000917	CcSEcCtD
Vincristine—Decreased appetite—Epirubicin—thyroid cancer	6.08e-05	0.000904	CcSEcCtD
Vincristine—Hypotension—Doxorubicin—thyroid cancer	6.05e-05	0.000899	CcSEcCtD
Vincristine—Gastrointestinal disorder—Epirubicin—thyroid cancer	6.04e-05	0.000897	CcSEcCtD
Vincristine—Fatigue—Epirubicin—thyroid cancer	6.03e-05	0.000896	CcSEcCtD
Vincristine—Constipation—Epirubicin—thyroid cancer	5.99e-05	0.000889	CcSEcCtD
Vincristine—Pain—Epirubicin—thyroid cancer	5.99e-05	0.000889	CcSEcCtD
Vincristine—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	5.9e-05	0.000876	CcSEcCtD
Vincristine—Insomnia—Doxorubicin—thyroid cancer	5.86e-05	0.00087	CcSEcCtD
Vincristine—Paraesthesia—Doxorubicin—thyroid cancer	5.82e-05	0.000864	CcSEcCtD
Vincristine—Gastrointestinal pain—Epirubicin—thyroid cancer	5.72e-05	0.00085	CcSEcCtD
Vincristine—Decreased appetite—Doxorubicin—thyroid cancer	5.63e-05	0.000836	CcSEcCtD
Vincristine—Gastrointestinal disorder—Doxorubicin—thyroid cancer	5.59e-05	0.00083	CcSEcCtD
Vincristine—Fatigue—Doxorubicin—thyroid cancer	5.58e-05	0.000829	CcSEcCtD
Vincristine—Constipation—Doxorubicin—thyroid cancer	5.54e-05	0.000822	CcSEcCtD
Vincristine—Pain—Doxorubicin—thyroid cancer	5.54e-05	0.000822	CcSEcCtD
Vincristine—Abdominal pain—Epirubicin—thyroid cancer	5.53e-05	0.000822	CcSEcCtD
Vincristine—Body temperature increased—Epirubicin—thyroid cancer	5.53e-05	0.000822	CcSEcCtD
Vincristine—Gastrointestinal pain—Doxorubicin—thyroid cancer	5.3e-05	0.000786	CcSEcCtD
Vincristine—Hypersensitivity—Epirubicin—thyroid cancer	5.16e-05	0.000766	CcSEcCtD
Vincristine—Body temperature increased—Doxorubicin—thyroid cancer	5.12e-05	0.00076	CcSEcCtD
Vincristine—Abdominal pain—Doxorubicin—thyroid cancer	5.12e-05	0.00076	CcSEcCtD
Vincristine—Asthenia—Epirubicin—thyroid cancer	5.02e-05	0.000746	CcSEcCtD
Vincristine—RALBP1—EGF/EGFR Signaling Pathway—AKT1—thyroid cancer	4.89e-05	0.00113	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—TPR—thyroid cancer	4.84e-05	0.00112	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—CP—thyroid cancer	4.84e-05	0.00112	CbGpPWpGaD
Vincristine—TUBB2B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.83e-05	0.00111	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.83e-05	0.00111	CbGpPWpGaD
Vincristine—Diarrhoea—Epirubicin—thyroid cancer	4.79e-05	0.000711	CcSEcCtD
Vincristine—Hypersensitivity—Doxorubicin—thyroid cancer	4.77e-05	0.000709	CcSEcCtD
Vincristine—TUBB4B—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.77e-05	0.0011	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CDK1—thyroid cancer	4.72e-05	0.00109	CbGpPWpGaD
Vincristine—TUBB3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.66e-05	0.00108	CbGpPWpGaD
Vincristine—CYP3A7—Biological oxidations—RXRA—thyroid cancer	4.65e-05	0.00107	CbGpPWpGaD
Vincristine—Asthenia—Doxorubicin—thyroid cancer	4.65e-05	0.00069	CcSEcCtD
Vincristine—Dizziness—Epirubicin—thyroid cancer	4.63e-05	0.000687	CcSEcCtD
Vincristine—SLC22A3—Metabolism—NDUFA13—thyroid cancer	4.62e-05	0.00107	CbGpPWpGaD
Vincristine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	4.57e-05	0.00105	CbGpPWpGaD
Vincristine—TUBB2A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.52e-05	0.00104	CbGpPWpGaD
Vincristine—Vomiting—Epirubicin—thyroid cancer	4.45e-05	0.000661	CcSEcCtD
Vincristine—ABCB11—Metabolism—NDUFA13—thyroid cancer	4.43e-05	0.00102	CbGpPWpGaD
Vincristine—Diarrhoea—Doxorubicin—thyroid cancer	4.43e-05	0.000658	CcSEcCtD
Vincristine—TUBB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.42e-05	0.00102	CbGpPWpGaD
Vincristine—Rash—Epirubicin—thyroid cancer	4.41e-05	0.000655	CcSEcCtD
Vincristine—Dermatitis—Epirubicin—thyroid cancer	4.41e-05	0.000655	CcSEcCtD
Vincristine—Headache—Epirubicin—thyroid cancer	4.38e-05	0.000651	CcSEcCtD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CDK1—thyroid cancer	4.38e-05	0.00101	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—CHST14—thyroid cancer	4.35e-05	0.001	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—CP—thyroid cancer	4.3e-05	0.000992	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—TPR—thyroid cancer	4.3e-05	0.000992	CbGpPWpGaD
Vincristine—Dizziness—Doxorubicin—thyroid cancer	4.28e-05	0.000636	CcSEcCtD
Vincristine—ABCC3—Metabolism—NDUFA13—thyroid cancer	4.25e-05	0.000981	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TSHR—thyroid cancer	4.25e-05	0.000981	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	4.24e-05	0.000978	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	4.23e-05	0.000976	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PRKAR1A—thyroid cancer	4.18e-05	0.000965	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—CHST14—thyroid cancer	4.17e-05	0.000962	CbGpPWpGaD
Vincristine—Nausea—Epirubicin—thyroid cancer	4.16e-05	0.000617	CcSEcCtD
Vincristine—Vomiting—Doxorubicin—thyroid cancer	4.12e-05	0.000612	CcSEcCtD
Vincristine—Rash—Doxorubicin—thyroid cancer	4.08e-05	0.000606	CcSEcCtD
Vincristine—Dermatitis—Doxorubicin—thyroid cancer	4.08e-05	0.000606	CcSEcCtD
Vincristine—Headache—Doxorubicin—thyroid cancer	4.06e-05	0.000603	CcSEcCtD
Vincristine—TUBB2B—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.06e-05	0.000937	CbGpPWpGaD
Vincristine—TUBB6—Transmembrane transport of small molecules—RXRA—thyroid cancer	4.06e-05	0.000937	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	4.05e-05	0.000936	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TERT—thyroid cancer	4e-05	0.000924	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CDK1—thyroid cancer	4e-05	0.000924	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—CHST14—thyroid cancer	3.99e-05	0.000923	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—MEN1—thyroid cancer	3.99e-05	0.000922	CbGpPWpGaD
Vincristine—ABCC1—Disease—TRIM24—thyroid cancer	3.98e-05	0.000918	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.96e-05	0.000916	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—TPR—thyroid cancer	3.95e-05	0.000912	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—CP—thyroid cancer	3.95e-05	0.000912	CbGpPWpGaD
Vincristine—TUBB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.92e-05	0.000905	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—MINPP1—thyroid cancer	3.92e-05	0.000904	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CDK1—thyroid cancer	3.91e-05	0.000904	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.88e-05	0.000897	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—RXRA—thyroid cancer	3.86e-05	0.000892	CbGpPWpGaD
Vincristine—Nausea—Doxorubicin—thyroid cancer	3.85e-05	0.000571	CcSEcCtD
Vincristine—TUBB2A—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.79e-05	0.000876	CbGpPWpGaD
Vincristine—ABCC1—Disease—CHST14—thyroid cancer	3.74e-05	0.000863	CbGpPWpGaD
Vincristine—TUBB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.71e-05	0.000857	CbGpPWpGaD
Vincristine—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	3.63e-05	0.000838	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.63e-05	0.000837	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTCH1—thyroid cancer	3.61e-05	0.000834	CbGpPWpGaD
Vincristine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	3.61e-05	0.000833	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CDK1—thyroid cancer	3.58e-05	0.000826	CbGpPWpGaD
Vincristine—ABCC1—Disease—TRIM33—thyroid cancer	3.54e-05	0.000818	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—HPGD—thyroid cancer	3.5e-05	0.000809	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—MINPP1—thyroid cancer	3.45e-05	0.000796	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—MINPP1—thyroid cancer	3.41e-05	0.000789	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TERT—thyroid cancer	3.4e-05	0.000786	CbGpPWpGaD
Vincristine—CYP3A5—Biological oxidations—RXRA—thyroid cancer	3.36e-05	0.000776	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—HPGD—thyroid cancer	3.36e-05	0.000776	CbGpPWpGaD
Vincristine—TUBB4A—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.33e-05	0.000769	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—NDUFA13—thyroid cancer	3.33e-05	0.000769	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—SST—thyroid cancer	3.3e-05	0.000763	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—HPGD—thyroid cancer	3.22e-05	0.000744	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	3.22e-05	0.000743	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CALCA—thyroid cancer	3.18e-05	0.000734	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—TPR—thyroid cancer	3.13e-05	0.000723	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—CP—thyroid cancer	3.13e-05	0.000723	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—CHST14—thyroid cancer	3.13e-05	0.000723	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—CP—thyroid cancer	3.09e-05	0.000715	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—TPR—thyroid cancer	3.09e-05	0.000715	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.08e-05	0.000711	CbGpPWpGaD
Vincristine—TUBB4B—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.05e-05	0.000704	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	3.04e-05	0.000703	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.96e-05	0.000683	CbGpPWpGaD
Vincristine—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	2.94e-05	0.000679	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—NDUFA13—thyroid cancer	2.93e-05	0.000677	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—NDUFA13—thyroid cancer	2.9e-05	0.000671	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CDK1—thyroid cancer	2.88e-05	0.000665	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TERT—thyroid cancer	2.82e-05	0.000651	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—CHST14—thyroid cancer	2.75e-05	0.000636	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—CHST14—thyroid cancer	2.73e-05	0.00063	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.72e-05	0.000629	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	2.72e-05	0.000629	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	2.72e-05	0.000629	CbGpPWpGaD
Vincristine—SLC22A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.7e-05	0.000624	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	2.68e-05	0.000619	CbGpPWpGaD
Vincristine—TUBA4A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	2.64e-05	0.000611	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.61e-05	0.000603	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.59e-05	0.000597	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TERT—thyroid cancer	2.58e-05	0.000596	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—HPGD—thyroid cancer	2.52e-05	0.000583	CbGpPWpGaD
Vincristine—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	2.52e-05	0.000582	CbGpPWpGaD
Vincristine—ABCC3—Transmembrane transport of small molecules—RXRA—thyroid cancer	2.48e-05	0.000574	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—MINPP1—thyroid cancer	2.47e-05	0.00057	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—PPARG—thyroid cancer	2.44e-05	0.000563	CbGpPWpGaD
Vincristine—ABCC1—Disease—TCF7L1—thyroid cancer	2.36e-05	0.000546	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.34e-05	0.000541	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	2.33e-05	0.000538	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.32e-05	0.000535	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—CCND1—thyroid cancer	2.31e-05	0.000534	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRG1—thyroid cancer	2.31e-05	0.000533	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—HPGD—thyroid cancer	2.22e-05	0.000513	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—HPGD—thyroid cancer	2.2e-05	0.000508	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle, Mitotic—CCND1—thyroid cancer	2.2e-05	0.000508	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—NRAS—thyroid cancer	2.11e-05	0.000487	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—NDUFA13—thyroid cancer	2.1e-05	0.000485	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TERT—thyroid cancer	2.07e-05	0.000479	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	2.05e-05	0.000473	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	2.04e-05	0.000471	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—TPR—thyroid cancer	2.01e-05	0.000465	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HIF1A—thyroid cancer	1.98e-05	0.000458	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PRKAR1A—thyroid cancer	1.98e-05	0.000457	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—CHST14—thyroid cancer	1.97e-05	0.000456	CbGpPWpGaD
Vincristine—ABCC2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.97e-05	0.000455	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—CCND1—thyroid cancer	1.97e-05	0.000454	CbGpPWpGaD
Vincristine—ABCC1—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.95e-05	0.000449	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—TPR—thyroid cancer	1.93e-05	0.000446	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PRKAR1A—thyroid cancer	1.9e-05	0.000438	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—MINPP1—thyroid cancer	1.86e-05	0.00043	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—TPR—thyroid cancer	1.85e-05	0.000427	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.82e-05	0.000421	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PRKAR1A—thyroid cancer	1.82e-05	0.00042	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—KRAS—thyroid cancer	1.82e-05	0.00042	CbGpPWpGaD
Vincristine—ABCC1—Disease—TPR—thyroid cancer	1.73e-05	0.0004	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.72e-05	0.000397	CbGpPWpGaD
Vincristine—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	1.71e-05	0.000395	CbGpPWpGaD
Vincristine—ABCC1—Disease—PRKAR1A—thyroid cancer	1.7e-05	0.000393	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle, Mitotic—CCND1—thyroid cancer	1.67e-05	0.000385	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.65e-05	0.000381	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—BRAF—thyroid cancer	1.64e-05	0.000379	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—CCND1—thyroid cancer	1.63e-05	0.000376	CbGpPWpGaD
Vincristine—ABCC1—Disease—MEN1—thyroid cancer	1.63e-05	0.000376	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—TP53—thyroid cancer	1.61e-05	0.000373	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—HPGD—thyroid cancer	1.59e-05	0.000367	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—NDUFA13—thyroid cancer	1.58e-05	0.000366	CbGpPWpGaD
Vincristine—CYP3A4—Biological oxidations—RXRA—thyroid cancer	1.56e-05	0.000361	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—HRAS—thyroid cancer	1.54e-05	0.000357	CbGpPWpGaD
Vincristine—TUBA4A—Cell Cycle—TP53—thyroid cancer	1.52e-05	0.000352	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—SLC5A5—thyroid cancer	1.51e-05	0.000348	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—CCND1—thyroid cancer	1.49e-05	0.000344	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—CHST14—thyroid cancer	1.49e-05	0.000344	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	1.47e-05	0.00034	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	1.47e-05	0.00034	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—TPR—thyroid cancer	1.45e-05	0.000335	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	1.45e-05	0.000334	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—SLC5A5—thyroid cancer	1.44e-05	0.000333	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PRKAR1A—thyroid cancer	1.43e-05	0.000329	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—SLC5A5—thyroid cancer	1.38e-05	0.00032	CbGpPWpGaD
Vincristine—TUBA4A—Hemostasis—AKT1—thyroid cancer	1.36e-05	0.000315	CbGpPWpGaD
Vincristine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	1.36e-05	0.000315	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.35e-05	0.000313	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.3e-05	0.0003	CbGpPWpGaD
Vincristine—TUBB—Cell Cycle—TP53—thyroid cancer	1.3e-05	0.000299	CbGpPWpGaD
Vincristine—ABCC1—Disease—CALCA—thyroid cancer	1.3e-05	0.000299	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	1.29e-05	0.000298	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—TPR—thyroid cancer	1.28e-05	0.000294	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—RXRA—thyroid cancer	1.27e-05	0.000292	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—TPR—thyroid cancer	1.26e-05	0.000292	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PRKAR1A—thyroid cancer	1.25e-05	0.00029	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PRKAR1A—thyroid cancer	1.24e-05	0.000287	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—RXRA—thyroid cancer	1.21e-05	0.00028	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—HPGD—thyroid cancer	1.2e-05	0.000277	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—CCND1—thyroid cancer	1.2e-05	0.000277	CbGpPWpGaD
Vincristine—ABCB11—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.18e-05	0.000273	CbGpPWpGaD
Vincristine—ABCC1—Disease—CDK1—thyroid cancer	1.17e-05	0.000271	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—RXRA—thyroid cancer	1.16e-05	0.000269	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	1.16e-05	0.000267	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—PTEN—thyroid cancer	1.16e-05	0.000267	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—MINPP1—thyroid cancer	1.15e-05	0.000265	CbGpPWpGaD
Vincristine—ABCC3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.13e-05	0.000261	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	1.1e-05	0.000254	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—SLC5A5—thyroid cancer	1.08e-05	0.000251	CbGpPWpGaD
Vincristine—TUBB4A—Cell Cycle—TP53—thyroid cancer	1.07e-05	0.000248	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	1.05e-05	0.000242	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—NRAS—thyroid cancer	1.03e-05	0.000238	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	1.02e-05	0.000235	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	1.01e-05	0.000233	CbGpPWpGaD
Vincristine—TUBB4B—Cell Cycle—TP53—thyroid cancer	9.82e-06	0.000227	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—NDUFA13—thyroid cancer	9.76e-06	0.000225	CbGpPWpGaD
Vincristine—NR0B1—Gene Expression—AKT1—thyroid cancer	9.64e-06	0.000223	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—SLC5A5—thyroid cancer	9.55e-06	0.00022	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—SLC5A5—thyroid cancer	9.46e-06	0.000219	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRG1—thyroid cancer	9.41e-06	0.000217	CbGpPWpGaD
Vincristine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	9.26e-06	0.000214	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—CHST14—thyroid cancer	9.17e-06	0.000212	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—TPR—thyroid cancer	9.14e-06	0.000211	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—RXRA—thyroid cancer	9.11e-06	0.00021	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	8.99e-06	0.000208	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—KRAS—thyroid cancer	8.88e-06	0.000205	CbGpPWpGaD
Vincristine—ABCC1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	8.86e-06	0.000205	CbGpPWpGaD
Vincristine—ABCC1—Disease—TERT—thyroid cancer	8.45e-06	0.000195	CbGpPWpGaD
Vincristine—ABCC1—Disease—HIF1A—thyroid cancer	8.08e-06	0.000187	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—RXRA—thyroid cancer	8.02e-06	0.000185	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PPARG—thyroid cancer	7.99e-06	0.000185	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—RXRA—thyroid cancer	7.95e-06	0.000184	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—TP53—thyroid cancer	7.9e-06	0.000182	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	7.76e-06	0.000179	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PPARG—thyroid cancer	7.66e-06	0.000177	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—HRAS—thyroid cancer	7.55e-06	0.000174	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—HPGD—thyroid cancer	7.4e-06	0.000171	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PPARG—thyroid cancer	7.34e-06	0.00017	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—TPR—thyroid cancer	6.89e-06	0.000159	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	6.89e-06	0.000159	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—SLC5A5—thyroid cancer	6.84e-06	0.000158	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	6.78e-06	0.000157	CbGpPWpGaD
Vincristine—ABCC1—Disease—BRAF—thyroid cancer	6.69e-06	0.000155	CbGpPWpGaD
Vincristine—RALBP1—Signaling Pathways—AKT1—thyroid cancer	6.67e-06	0.000154	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTGS2—thyroid cancer	6.29e-06	0.000145	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTGS2—thyroid cancer	6.03e-06	0.000139	CbGpPWpGaD
Vincristine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	5.82e-06	0.000134	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTGS2—thyroid cancer	5.78e-06	0.000133	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PPARG—thyroid cancer	5.75e-06	0.000133	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—RXRA—thyroid cancer	5.75e-06	0.000133	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—PTEN—thyroid cancer	5.48e-06	0.000127	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTGS2—thyroid cancer	5.41e-06	0.000125	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—PTEN—thyroid cancer	5.26e-06	0.000121	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—SLC5A5—thyroid cancer	5.16e-06	0.000119	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PPARG—thyroid cancer	5.06e-06	0.000117	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—PTEN—thyroid cancer	5.04e-06	0.000116	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PPARG—thyroid cancer	5.02e-06	0.000116	CbGpPWpGaD
Vincristine—ABCC1—Disease—PTEN—thyroid cancer	4.71e-06	0.000109	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTGS2—thyroid cancer	4.53e-06	0.000105	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—RXRA—thyroid cancer	4.34e-06	0.0001	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—TPR—thyroid cancer	4.25e-06	9.81e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—NRAS—thyroid cancer	4.21e-06	9.71e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	4.18e-06	9.65e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTGS2—thyroid cancer	3.98e-06	9.2e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTGS2—thyroid cancer	3.95e-06	9.12e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—PTEN—thyroid cancer	3.95e-06	9.12e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PPARG—thyroid cancer	3.63e-06	8.38e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—KRAS—thyroid cancer	3.62e-06	8.36e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—PTEN—thyroid cancer	3.47e-06	8.02e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—PTEN—thyroid cancer	3.44e-06	7.95e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—SLC5A5—thyroid cancer	3.18e-06	7.34e-05	CbGpPWpGaD
Vincristine—SLC22A3—Metabolism—AKT1—thyroid cancer	3.16e-06	7.3e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—HRAS—thyroid cancer	3.08e-06	7.11e-05	CbGpPWpGaD
Vincristine—ABCB11—Metabolism—AKT1—thyroid cancer	3.03e-06	6.99e-05	CbGpPWpGaD
Vincristine—ABCC3—Metabolism—AKT1—thyroid cancer	2.9e-06	6.71e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTGS2—thyroid cancer	2.85e-06	6.59e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PPARG—thyroid cancer	2.74e-06	6.32e-05	CbGpPWpGaD
Vincristine—ABCC1—Disease—AKT1—thyroid cancer	2.72e-06	6.27e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—RXRA—thyroid cancer	2.67e-06	6.17e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—PTEN—thyroid cancer	2.49e-06	5.75e-05	CbGpPWpGaD
Vincristine—ABCC1—Metabolism—AKT1—thyroid cancer	2.28e-06	5.25e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTGS2—thyroid cancer	2.15e-06	4.97e-05	CbGpPWpGaD
Vincristine—ABCG2—Metabolism—AKT1—thyroid cancer	2e-06	4.62e-05	CbGpPWpGaD
Vincristine—CYP3A7—Metabolism—AKT1—thyroid cancer	1.98e-06	4.58e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—PTEN—thyroid cancer	1.88e-06	4.34e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PPARG—thyroid cancer	1.69e-06	3.9e-05	CbGpPWpGaD
Vincristine—CYP3A5—Metabolism—AKT1—thyroid cancer	1.43e-06	3.31e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTGS2—thyroid cancer	1.33e-06	3.06e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—PTEN—thyroid cancer	1.16e-06	2.67e-05	CbGpPWpGaD
Vincristine—ABCB1—Metabolism—AKT1—thyroid cancer	1.08e-06	2.5e-05	CbGpPWpGaD
Vincristine—CYP3A4—Metabolism—AKT1—thyroid cancer	6.67e-07	1.54e-05	CbGpPWpGaD
